Cubist Systematic Strategies LLC lowered its holdings in DocGo Inc. (NASDAQ:DCGO – Free Report) by 21.3% in the second quarter, HoldingsChannel.com reports. The firm owned 183,364 shares of the company’s stock after selling 49,510 shares during the quarter. Cubist Systematic Strategies LLC’s holdings in DocGo were worth $567,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also recently made changes to their positions in the company. Harbor Capital Advisors Inc. increased its position in shares of DocGo by 273.4% in the second quarter. Harbor Capital Advisors Inc. now owns 396,015 shares of the company’s stock worth $1,224,000 after purchasing an additional 289,964 shares during the period. Jacobs Levy Equity Management Inc. acquired a new stake in shares of DocGo in the 1st quarter valued at $672,000. Birchview Capital LP increased its stake in shares of DocGo by 15.4% in the 4th quarter. Birchview Capital LP now owns 150,000 shares of the company’s stock valued at $838,000 after purchasing an additional 20,000 shares during the last quarter. S Squared Technology LLC raised its holdings in shares of DocGo by 36.7% during the 4th quarter. S Squared Technology LLC now owns 1,024,438 shares of the company’s stock worth $5,727,000 after buying an additional 275,000 shares in the last quarter. Finally, Pasadena Private Wealth LLC lifted its position in shares of DocGo by 363.6% during the 1st quarter. Pasadena Private Wealth LLC now owns 395,487 shares of the company’s stock worth $1,598,000 after buying an additional 310,180 shares during the last quarter. Institutional investors and hedge funds own 56.44% of the company’s stock.
DocGo Trading Up 6.3 %
DocGo stock opened at $3.35 on Friday. The stock has a 50-day moving average price of $3.49 and a two-hundred day moving average price of $3.38. DocGo Inc. has a 12 month low of $2.75 and a 12 month high of $6.90. The company has a market capitalization of $340.25 million, a PE ratio of 16.75, a P/E/G ratio of 2.96 and a beta of 0.91.
Wall Street Analysts Forecast Growth
A number of research firms have issued reports on DCGO. Cantor Fitzgerald reiterated an “overweight” rating and issued a $5.00 target price on shares of DocGo in a research report on Friday, September 20th. Needham & Company LLC reaffirmed a “buy” rating and set a $7.00 price target on shares of DocGo in a report on Thursday, August 8th. Five equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of $6.10.
Check Out Our Latest Analysis on DocGo
DocGo Company Profile
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Further Reading
- Five stocks we like better than DocGo
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- The Outlook for Interest Rate Cuts Got Blown Out of the Water
- Do ETFs Pay Dividends? What You Need to Know
- 3 High-Risk, High-Reward Micro-Cap Stocks You Shouldn’t Ignore
- Conference Calls and Individual Investors
- 3 Bargain Stocks Positioned for Gains After Missing 2024’s Rally
Want to see what other hedge funds are holding DCGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocGo Inc. (NASDAQ:DCGO – Free Report).
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.